Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

squamous cell carcinoma of liver and intrahepatic biliary tract - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

squamous cell carcinoma of liver and intrahepatic biliary tract

MONDO:0018534

Also known as:squamous cell carcinoma of liver and IBT

Overview

Squamous cell carcinoma of liver and intrahepatic biliary tract is an extremely rare, primary, malignant liver and biliray tract epithelial tumor originating in the intrahepatic bile duct epithelium histologically characterized by the presence of keratinization and/or intracellular bridges. Patients typically present abdominal pain in the right upper quadrant, jaundice, nausea, vomiting, anorexia, weight loss, fever and/or dyspepsia.

ResearchLimited published research (5 articles)

Diagnosis

Biomarker and diagnostic research for squamous cell carcinoma of liver and intrahepatic biliary tract has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for squamous cell carcinoma of liver and intrahepatic biliary tract.

5 publications have been identified in PubMed for squamous cell carcinoma of liver and intrahepatic biliary tract. Research spans Case Report / Case Series (60%), Diagnostic / Biomarker (20%), and Review / Meta-Analysis (20%).

Recent Publications

Rikitake R (2025). [PMID: 40376725](https://pubmed.ncbi.nlm.nih.gov/40376725/). *Pathology international*. [Review / Meta-Analysis]
Benhamdane A (2024). [PMID: 38984177](https://pubmed.ncbi.nlm.nih.gov/38984177/). *European journal of case reports in internal medicine*. [Case Report / Case Series]
Pulappadi VP (2024). [PMID: 39822406](https://pubmed.ncbi.nlm.nih.gov/39822406/). *Cureus*. [Case Report / Case Series]
Gerber TS (2024). [PMID: 38212892](https://pubmed.ncbi.nlm.nih.gov/38212892/). *International journal of cancer*. [Diagnostic / Biomarker]
Ma QJ (2024). [PMID: 39071465](https://pubmed.ncbi.nlm.nih.gov/39071465/). *World journal of clinical oncology*. [Case Report / Case Series]

Data assembled from 3 of 12 sources · Last updated Sep 21, 2026, 12:28 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:424975

GARD

Genetic and Rare Diseases Info Center

GARD:21789

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

squamous cell carcinoma of liver and intrahepatic biliary tract

Overview

Diagnosis

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team